Legend Biotech (LEGN) Change in Receivables (2020 - 2025)

Legend Biotech has reported Change in Receivables for 6 years, with the latest figure at $25.8 million in Q3 2025.

• For the quarter ending Q3 2025, Change in Receivables rose 108.67% year-over-year to $25.8 million; the trailing twelve-month figure through Sep 2025 stood at -$72000.0 (down 125.17% YoY), and the FY2024 full-year result was $93.8 million, up 194.72% from the prior year.
• Change in Receivables for Q3 2025 stood at $25.8 million, up from -$26.2 million in the prior quarter.
• The five-year high for Change in Receivables was $96.7 million in Q1 2024, with the low at -$99.0 million in Q4 2023.
• Historically, Change in Receivables has averaged $4.0 million across 5 years, with a median of $34000.0 in 2023.
• Annual changes were most pronounced in 2023 — Change in Receivables plunged 319416.13% — and 2024, when it jumped 284411.76%.
• Legend Biotech's Change in Receivables stood at -$48.9 million in 2021, then surged by 99.94% to -$31000.0 in 2022, then sank by 319416.13% to -$99.0 million in 2023, then surged by 94.36% to -$5.6 million in 2024, then surged by 562.02% to $25.8 million in 2025.
• The last three Change in Receivables figures came in at $25.8 million (Q3 2025), -$26.2 million (Q2 2025), and $5.9 million (Q1 2025), per Business Quant data.